China opens market to Indian drugs with reduced tariffs
July 10, 2018Manufacturing and Production, Sales and Marketing China, India, pharma
India and China have reached an agreement aimed at reducing tariffs on Indian pharmaceuticals going between the world’s two most …
EMA issues global recall of heart drugs over cancer risk contamination
July 10, 2018Manufacturing and Production EMA, Europe, heart disease, pharma, valsartan
Several drugs designed for the treatment of high blood pressure and heart conditions have been recalled across Europe over fears …
Sanofi shut down French plant over “astronomical” emission levels
July 10, 2018Manufacturing and Production FNE, France, Sanofi, manufacturing, pharma, valproate
Sanofi announced yesterday that they have stopped production at their plant in the French Pyrenees following complaints that the factory …
NICE calls to limit antibiotic use in COPD over antimicrobial resistance fears
July 10, 2018Manufacturing and Production, Medical Communications, Research and Development COPD, NICE, antimicrobial resistance, chronic obstructive pulmonary disease, pharma
NICE have published a draft antimicrobial prescribing guide recommending that healthcare professionals should consider the risk of antimicrobial resistance when …
Trump slams Pfizer over price hikes, Pfizer responds
July 10, 2018Manufacturing and Production, Sales and Marketing Donald Trump, Drug pricing, Pfizer, Trump, pharma
Price hiking in the pharmaceutical industry continues to persist, and has become ever more prominent in the public sphere thanks …
MSD’s ulcerative colitis drug scores expanded indication in Europe
July 9, 2018Sales and Marketing Europe, MSD, pharma, ulcerative colitis
New Jersey-based multinational MSD have announced that the European Commission (EC) has approved Simponi (golimumab) for early dose optimisation in …
Eisai and Biogen’s Alzheimer’s drug slows progression in Phase 2 trials
July 9, 2018Research and Development, Sales and Marketing
The Japan-based Eisai and Massachusetts-based Biogen have announced that experimental drug BAN2401 has demonstrated efficacy in slowing the progression of …
Extended use of breast cancer drug tamoxifen linked to increased endometrial cancer risk
July 9, 2018Research and Development, Sales and Marketing Cancer, breast cancer, endometrial cancer, pharma, tamoxifen
New evidence published in the British Journal of Surgery has indicated a troubling link between long-term use of the breast …
Insider Interview: Biosimilars to balance the books
July 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, bisoimilars, multiple sclerosis
Jean-Yves Brault, Country Manager at Mylan UK, discusses how biosimilars are going to play an important role in driving down …
Scotland approves first-line treatment for advanced kidney cancer
July 9, 2018Sales and Marketing Cancer, Scotland, fotivda, rcc, tivozanib
The Scottish Medicines Consortium has approved the use of EUSA Pharma’s Fotivda (tivozanib) as a first-line treatment for people with …
Regulus cuts workforce by 60%, halts studies in major restructure
July 9, 2018Sales and Marketing Regulus, pharma
California-based biotech Regulus Therapeutics has announced it is to strip away more than half of its total workforce as part …
Teva to relocate US HQ to New Jersey, affecting over 1,000 jobs
July 6, 2018Manufacturing and Production, Medical Communications Teva, US, new jersey, pharma, philadelphia
As the Israeli firm presses on with attempts to cut back on costs and streamline operations, Teva has announced plans …
Top Ten most popular articles on Pharmafile.com this week
July 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Astrazenaca, Donald Trump, Pfizer, pharma, top ten
As the first week of July comes to an end we take a look over the most popular stories of …
Zynerba’s cannabis-based transdermal patch fails at Phase 1, shares slide 21%
July 6, 2018Medical Communications, Research and Development GW Pharma, Zynerba, cannabidinol, cannabinol, cannabis, pharma, trial failure
As public focus on the issue of medicinal cannabis continues to grow, Zynerba Pharmaceuticals has announced that its transdermal tetrahydrocannabinol …
Missouri appeals court overturns $55m J&J verdict
July 6, 2018Medical Communications, Sales and Marketing Cancer, J&J, JJ, Litigation, appeal, pharma
A $55 million verdict against the multinational pharmaceutical company Johnson & Johnson has been overturned by an appeals court in …
Illegally manufactured fentanyl drives deaths in Ontario
July 5, 2018Medical Communications Crisis, Ontario, canda, epidemic, fentanyl, opioid
Illicit forms of the powerful opioid fentanyl have been driving increased rates of opioid-related deaths in the Canadian province of …
Ipsen reveals positive Phase 3 data of Cabometyx in liver cancer
July 5, 2018Research and Development Cabometyx, Cancer, ipsen, liver cancer, pharma
French pharmaceutical company Ipsen has announced that The New England Journal of Medicine has published the results of a Phase …
CHMP recommends Novartis’ CAR-T therapy Kymriah for EU approval
July 5, 2018Sales and Marketing CAR-T, CHMP, EMA, EU, Kymriah, Novartis, pharma
The Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Medicines Agency (EMA) approve Novartis’ CAR-T …
Global animal health market set to be worth $44.2 billion by 2020
July 5, 2018Manufacturing and Production, Sales and Marketing Antibiotics, agriculture, animal, health, meat, pharma
The global animal health market is predicted to reach a value of $44.2 billion dollars by 2020, according to analysts …
Takeda to sell Osaka site to soften Shire deal’s financial impact
July 5, 2018Manufacturing and Production, Sales and Marketing Japan, Osaka, Shire, Takeda, acquisition, pharma
It’s one of the biggest acquisitions the industry has seen at a total value of $63 billion and after weeks …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
